Natixis Advisors’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $483K | Buy |
24,765
+218
| +0.9% | +$4.33K | ﹤0.01% | 1695 |
|
|
2026
Q1 | $472K | Buy |
24,547
+193
| +0.8% | +$3.8K | ﹤0.01% | 1565 |
|
|
2025
Q4 | $461K | Sell |
24,354
-3,310
| -12% | -$61.3K | ﹤0.01% | 1468 |
|
|
2025
Q3 | $516K | Buy |
27,664
+598
| +2% | +$11.2K | ﹤0.01% | 1483 |
|
|
2025
Q2 | $499K | Buy |
27,066
+668
| +3% | +$11.9K | ﹤0.01% | 1465 |
|
|
2025
Q1 | $461K | Sell |
26,398
-1,204
| -4% | -$20.3K | ﹤0.01% | 1470 |
|
|
2024
Q4 | $478K | Sell |
27,602
-744
| -3% | -$13.6K | ﹤0.01% | 1482 |
|
|
2024
Q3 | $528K | Buy |
28,346
+1,739
| +7% | +$29.3K | ﹤0.01% | 1446 |
|
|
2024
Q2 | $410K | Buy |
26,607
+370
| +1% | +$5.29K | ﹤0.01% | 1474 |
|
|
2024
Q1 | $388K | Buy |
26,237
+3,967
| +18% | +$54.9K | ﹤0.01% | 1436 |
|
|
2023
Q4 | $317K | Buy |
22,270
+1,696
| +8% | +$24.1K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $287K | Buy |
+20,574
| New | +$263K | ﹤0.01% | 1446 |
|
|
2022
Q4 | – | Sell |
-27,205
| Closed | -$357K | – | 1505 |
|
|
2022
Q3 | $357K | Buy |
27,205
+4,955
| +22% | +$73.2K | ﹤0.01% | 1353 |
|
|
2022
Q2 | $311K | Buy |
+22,250
| New | +$297K | ﹤0.01% | 1367 |
|
|
2019
Q1 | – | Sell |
-53,837
| Closed | -$887K | – | 1085 |
|
|
2018
Q4 | $887K | Sell |
53,837
-28,098
| -34% | -$566K | 0.01% | 933 |
|
|
2018
Q3 | $1.89M | Buy |
81,935
+4,983
| +6% | +$113K | 0.02% | 783 |
|
|
2018
Q2 | $1.67M | Buy |
76,952
+4,196
| +6% | +$82K | 0.02% | 806 |
|
|
2018
Q1 | $1.28M | Buy |
72,756
+26,756
| +58% | +$472K | 0.01% | 867 |
|
|
2017
Q4 | $863K | Buy |
46,000
+20,128
| +78% | +$400K | 0.01% | 906 |
|
|
2017
Q3 | $567K | Buy |
+25,872
| New | +$585K | 0.01% | 969 |
|
|
2016
Q3 | – | Sell |
-115,857
| Closed | -$2.39M | – | 1012 |
|
|
2016
Q2 | $2.39M | Sell |
115,857
-8,398
| -7% | -$175K | 0.03% | 579 |
|
|
2016
Q1 | $2.5M | Sell |
124,255
-41,338
| -25% | -$792K | 0.04% | 554 |
|
|
2015
Q4 | $3.35M | Sell |
165,593
-7,695
| -4% | -$162K | 0.05% | 451 |
|
|
2015
Q3 | $4.02M | Buy |
173,288
+3,237
| +2% | +$82.6K | 0.07% | 399 |
|
|
2015
Q2 | $4.38M | Buy |
170,051
+331
| +0.2% | +$9.4K | 0.07% | 397 |
|
|
2015
Q1 | $5.63M | Sell |
169,720
-1,521
| -0.9% | -$49.4K | 0.1% | 305 |
|
|
2014
Q4 | $5.2M | Sell |
171,241
-3,382
| -2% | -$93.2K | 0.1% | 318 |
|
|
2014
Q3 | $4.25M | Sell |
174,623
-179,563
| -51% | -$4.98M | 0.09% | 364 |
|
|
2014
Q2 | $10.2M | Sell |
354,186
-13,556
| -4% | -$394K | 0.15% | 210 |
|
|
2014
Q1 | $10.3M | Buy |
367,742
+2,622
| +0.7% | +$72K | 0.16% | 202 |
|
|
2013
Q4 | $9.54M | Sell |
365,120
-6,494
| -2% | -$167K | 0.16% | 201 |
|
|
2013
Q3 | $8.55M | Sell |
371,614
-3,092
| -0.8% | -$76.2K | 0.16% | 210 |
|
|
2013
Q2 | $9.78M | Buy |
+374,706
| New | +$10.8M | 0.19% | 148 |
|
Other funds holding SBRA
CIM
Natixis Advisors's SBRA Position: Q2 2026 in Review
Natixis Advisors increased its Sabra Healthcare REIT (SBRA) stake by 0.89% in Q2 2026, buying an estimated $4.33K and bringing the position to 24,765 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #1695.
Natixis Advisors first reported a position in SBRA in Q2 2013 and has held it in 33 quarters since. The position peaked at $10.3M in Q1 2014. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Natixis Advisors held 24,765 shares of Sabra Healthcare REIT worth $483K as of Q2 2026.
- Natixis Advisors bought 218 Sabra Healthcare REIT shares in Q2 2026, an estimated $4.33K.
- Sabra Healthcare REIT made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1695 holding.
- Natixis Advisors first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 33 quarters since.
- Natixis Advisors's Sabra Healthcare REIT position peaked at $10.3M in Q1 2014.
- 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.